Results 41 to 50 of about 14,161,714 (418)

Dynamic generation of spin spirals of moiré trapped carriers via exciton mediated spin interactions [PDF]

open access: yes, 2022
Stacking transition metal dichalcogenides (TMDs) to form moir\'e superlattices has provided exciting opportunities to explore many-body correlation phenomena of the moir\'e trapped carriers. TMDs bilayers, on the other hand, host long-lived interlayer exciton (IX), an elementary excitation of long spin-valley lifetime that can be optically or ...
arxiv   +1 more source

CA-IX-Expressing Small Extracellular Vesicles (sEVs) Are Released by Melanoma Cells under Hypoxia and in the Blood of Advanced Melanoma Patients [PDF]

open access: yes, 2023
Cutaneous melanoma is a highly aggressive skin cancer, with poor prognosis. The tumor microenvironment is characterized by areas of hypoxia. Carbonic anhydrase IX (CA-IX) is a marker of tumor hypoxia and its expression is regulated by hypoxia-inducible ...
Carraro F.   +7 more
core   +1 more source

Systemic delivery of factor IX messenger RNA for protein replacement therapy

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2017
Significance Abnormal gene expression is the underlying cause for many pathological states, and restoring normalcy through overexpression or knockdown is a conceptually simple solution.
Suvasini Ramaswamy   +7 more
semanticscholar   +1 more source

TREATMENT OF HEMOPHILIA WITH HUMAN FACTORIX PRODUCED IN MAMIMARY TISSUE OF TRANSGENIC MAMMALS [PDF]

open access: yes, 2008
Recombinant Factor IX characterized by a high percentage of active protein can be obtained in the milk of transgenic animals that incorporate chimeric DNA molecules according to the present invention.
Drohan, William N.   +4 more
core   +3 more sources

Low‐factor consumption for major surgery in haemophilia B with long‐acting recombinant glycoPEGylated factor IX

open access: yesHaemophilia, 2017
Surgery in patients with haemophilia B carries a high risk of excessive bleeding and requires adequate haemostatic control until wound healing. Nonacog beta pegol, a long‐acting recombinant glycoPEGylated factor IX (FIX), was used in the perioperative ...
Miguel A. Escobar   +11 more
semanticscholar   +1 more source

Blood coagulation parameters in fallow deer (Dama dama)

open access: yesVeterinární Medicína, 2011
There are frequent reports from around the world of wild animals being poisoned with anticoagulants. Granulated baits can result in primary or secondary poisoning of non-target animals.
Z. Siroka   +5 more
doaj   +1 more source

Treatment planning with a 2.5 MV photon beam for radiation therapy

open access: yesJournal of Applied Clinical Medical Physics, Volume 23, Issue 12, December 2022., 2022
Abstract Purpose The shallow depth of maximum dose and higher dose fall‐off gradient of a 2.5 MV beam along the central axis that is available for imaging on linear accelerators is investigated for treatment of shallow tumors and sparing the organs at risk (OARs) beyond it.
Navid Khaledi   +5 more
wiley   +1 more source

Scale-factor duality in string Bianchi cosmologies [PDF]

open access: yes, 1999
We apply the scale factor duality transformations introduced in the context of the effective string theory to the anisotropic Bianchi-type models. We find dual models for all the Bianchi-types [except for types $VIII$ and $IX$] and construct for each of ...
Copeland E. J.   +3 more
core   +4 more sources

A computer‐based model to assess costs associated with the use of factor VIII and factor IX one‐stage and chromogenic activity assays

open access: yesJournal of Thrombosis and Haemostasis, 2016
Essentials Chromogenic factor VIII and factor IX assays have not been widely adopted partly due to perceived cost. Chromogenic assays may be needed for monitoring therapy with some extended half‐life concentrates.
S. Kitchen   +11 more
semanticscholar   +1 more source

“Prevalence of Inhibitors in Hemophilia Patients and its Clinical Implications”: A Study of 276 Patients in Western India

open access: yesGlobal Journal of Transfusion Medicine, 2019
Introduction: Hemophilia is an X-linked congenital bleeding disorder caused by a deficiency of coagulation factor VIII (FVIII) in hemophilia A (HA) or factor IX (FIX) in hemophilia B (HB).
Sangita Darshan Shah   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy